vs
Side-by-side financial comparison of OneStream, Inc. (OS) and Bio-Techne (TECH). Click either name above to swap in a different company.
Bio-Techne is the larger business by last-quarter revenue ($295.9M vs $163.7M, roughly 1.8× OneStream, Inc.). Bio-Techne runs the higher net margin — 12.8% vs 0.6%, a 12.2% gap on every dollar of revenue. On growth, OneStream, Inc. posted the faster year-over-year revenue change (23.6% vs -6.4%). Over the past eight quarters, OneStream, Inc.'s revenue compounded faster (21.8% CAGR vs 4.2%).
Blue Stream provides cable television, cable telephone, DVR, and up to 1 GIG Internet speed broadband services to customers in the Florida communities of Coral Springs and Weston.
Bio-Techne Corporation is an American life sciences company that develops, manufactures and sells life science reagents, instruments and services for the research, diagnostic, and bioprocessing markets.
OS vs TECH — Head-to-Head
Income Statement — Q4 FY2025 vs Q2 FY2026
| Metric | | |
|---|---|---|
| Revenue | $163.7M | $295.9M |
| Net Profit | $999.0K | $38.0M |
| Gross Margin | 69.8% | 64.6% |
| Operating Margin | -3.2% | 18.4% |
| Net Margin | 0.6% | 12.8% |
| Revenue YoY | 23.6% | -6.4% |
| Net Profit YoY | — | 68.3% |
| EPS (diluted) | — | $0.24 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $163.7M | $295.9M | ||
| Q3 25 | $154.3M | — | ||
| Q2 25 | $147.6M | $317.0M | ||
| Q1 25 | $136.3M | $316.2M | ||
| Q4 24 | $132.5M | $297.0M | ||
| Q3 24 | $129.1M | $289.5M | ||
| Q2 24 | $117.5M | $306.1M | ||
| Q1 24 | $110.3M | $303.4M |
| Q4 25 | $999.0K | $38.0M | ||
| Q3 25 | $-8.8M | — | ||
| Q2 25 | $-18.4M | $-17.7M | ||
| Q1 25 | $-24.0M | $22.6M | ||
| Q4 24 | — | $34.9M | ||
| Q3 24 | $-171.9M | $33.6M | ||
| Q2 24 | $-7.8M | $40.6M | ||
| Q1 24 | $-5.0M | $49.1M |
| Q4 25 | 69.8% | 64.6% | ||
| Q3 25 | 68.1% | — | ||
| Q2 25 | 68.6% | 62.7% | ||
| Q1 25 | 68.0% | 67.9% | ||
| Q4 24 | 66.8% | 65.3% | ||
| Q3 24 | 50.1% | 63.2% | ||
| Q2 24 | 68.5% | 66.4% | ||
| Q1 24 | 69.1% | 67.4% |
| Q4 25 | -3.2% | 18.4% | ||
| Q3 25 | -11.3% | — | ||
| Q2 25 | -21.8% | -7.5% | ||
| Q1 25 | -29.3% | 12.2% | ||
| Q4 24 | -35.8% | 16.0% | ||
| Q3 24 | -197.6% | 13.8% | ||
| Q2 24 | -9.8% | 15.0% | ||
| Q1 24 | -4.9% | 22.1% |
| Q4 25 | 0.6% | 12.8% | ||
| Q3 25 | -5.7% | — | ||
| Q2 25 | -12.5% | -5.6% | ||
| Q1 25 | -17.6% | 7.1% | ||
| Q4 24 | — | 11.7% | ||
| Q3 24 | -133.1% | 11.6% | ||
| Q2 24 | -6.7% | 13.3% | ||
| Q1 24 | -4.5% | 16.2% |
| Q4 25 | — | $0.24 | ||
| Q3 25 | — | — | ||
| Q2 25 | — | $-0.11 | ||
| Q1 25 | — | $0.14 | ||
| Q4 24 | — | $0.22 | ||
| Q3 24 | $-1.06 | $0.21 | ||
| Q2 24 | — | $0.26 | ||
| Q1 24 | — | $0.31 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $693.6M | $172.9M |
| Total DebtLower is stronger | — | $260.0M |
| Stockholders' EquityBook value | $504.7M | $2.0B |
| Total Assets | $1.0B | $2.5B |
| Debt / EquityLower = less leverage | — | 0.13× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $693.6M | $172.9M | ||
| Q3 25 | $653.9M | — | ||
| Q2 25 | $652.1M | $162.2M | ||
| Q1 25 | $593.9M | $140.7M | ||
| Q4 24 | $544.2M | $177.5M | ||
| Q3 24 | $495.5M | $187.5M | ||
| Q2 24 | $140.5M | $152.9M | ||
| Q1 24 | — | $145.3M |
| Q4 25 | — | $260.0M | ||
| Q3 25 | — | — | ||
| Q2 25 | — | $346.0M | ||
| Q1 25 | — | $330.0M | ||
| Q4 24 | — | $300.0M | ||
| Q3 24 | — | $300.0M | ||
| Q2 24 | — | $319.0M | ||
| Q1 24 | — | $389.0M |
| Q4 25 | $504.7M | $2.0B | ||
| Q3 25 | $472.1M | — | ||
| Q2 25 | $458.2M | $1.9B | ||
| Q1 25 | $412.9M | $2.0B | ||
| Q4 24 | $386.2M | $2.1B | ||
| Q3 24 | $458.2M | $2.1B | ||
| Q2 24 | $97.5M | $2.1B | ||
| Q1 24 | $102.5M | $2.0B |
| Q4 25 | $1.0B | $2.5B | ||
| Q3 25 | $949.4M | — | ||
| Q2 25 | $910.5M | $2.6B | ||
| Q1 25 | $867.3M | $2.6B | ||
| Q4 24 | $823.2M | $2.7B | ||
| Q3 24 | $750.1M | $2.7B | ||
| Q2 24 | $379.7M | $2.7B | ||
| Q1 24 | — | $2.7B |
| Q4 25 | — | 0.13× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | 0.18× | ||
| Q1 25 | — | 0.16× | ||
| Q4 24 | — | 0.14× | ||
| Q3 24 | — | 0.14× | ||
| Q2 24 | — | 0.15× | ||
| Q1 24 | — | 0.19× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $25.8M | — |
| Free Cash FlowOCF − Capex | $25.6M | — |
| FCF MarginFCF / Revenue | 15.7% | — |
| Capex IntensityCapex / Revenue | 0.1% | — |
| Cash ConversionOCF / Net Profit | 25.79× | — |
| TTM Free Cash FlowTrailing 4 quarters | $95.6M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $25.8M | — | ||
| Q3 25 | $5.0M | — | ||
| Q2 25 | $29.7M | $98.2M | ||
| Q1 25 | $36.2M | $41.1M | ||
| Q4 24 | — | $84.3M | ||
| Q3 24 | $2.4M | $63.9M | ||
| Q2 24 | $8.1M | $75.5M | ||
| Q1 24 | $25.5M | $81.0M |
| Q4 25 | $25.6M | — | ||
| Q3 25 | $4.8M | — | ||
| Q2 25 | $29.4M | $93.3M | ||
| Q1 25 | $35.8M | $31.0M | ||
| Q4 24 | — | $77.5M | ||
| Q3 24 | $1.3M | $54.7M | ||
| Q2 24 | $7.7M | $57.5M | ||
| Q1 24 | $24.9M | $64.5M |
| Q4 25 | 15.7% | — | ||
| Q3 25 | 3.1% | — | ||
| Q2 25 | 19.9% | 29.4% | ||
| Q1 25 | 26.3% | 9.8% | ||
| Q4 24 | — | 26.1% | ||
| Q3 24 | 1.0% | 18.9% | ||
| Q2 24 | 6.6% | 18.8% | ||
| Q1 24 | 22.5% | 21.3% |
| Q4 25 | 0.1% | — | ||
| Q3 25 | 0.1% | — | ||
| Q2 25 | 0.2% | 1.5% | ||
| Q1 25 | 0.3% | 3.2% | ||
| Q4 24 | — | 2.3% | ||
| Q3 24 | 0.8% | 3.2% | ||
| Q2 24 | 0.3% | 5.9% | ||
| Q1 24 | 0.6% | 5.4% |
| Q4 25 | 25.79× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | 1.82× | ||
| Q4 24 | — | 2.42× | ||
| Q3 24 | — | 1.90× | ||
| Q2 24 | — | 1.86× | ||
| Q1 24 | — | 1.65× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
OS
| Subscription And Circulation | $150.3M | 92% |
| Professional Services And Other | $9.4M | 6% |
| License | $4.0M | 2% |
TECH
| Diagnostics And Spatial Biology | $81.2M | 27% |
| EMEA Excluding UK | $75.4M | 25% |
| Other | $42.4M | 14% |
| Instruments | $29.6M | 10% |
| APAC Excluding Greater China | $22.7M | 8% |
| Services | $22.3M | 8% |
| GB | $13.7M | 5% |
| Royalty | $8.5M | 3% |
